Research

Together, the CHA2DS2-VASc and Intermountain risk scores identify people with atrial fibrillation who may develop dementia.

Graves KG, et al. Heart Rhythm 2019;16:3-9.

Use of the Intermountain Chronic Disease Model (ICHRON) to identify people with no major chronic diseases who may develop a cardiovascular or cardiopulmonary disease in the future.

May HT, et a. Mayo Clin Proc 2019;doi: 10.1016/j.mayocp.2018.06.029.

IMACE risk score determines the need for different levels of clinical care intensity after a heart attack or stent placement.

Horne BD, et al. Open Heart 2018;5:e000723.

Use of the Intermountain Risk Score among patients with stent placement to predict bleeding and in-hospital mortality.

Graves KG, et al. Clin Chim Acta 2018;482:166-171. 

The Laboratory-based Intermountain Validated Exacerbation (LIVE) score for chronic obstructive pulmonary disease risk prediction.

Blagev DP, et al. Front Med 2018;5:173. 

Expansion of understanding regarding the red cell distribution width risk score component and sizes of red blood cells.

Horne BD, et al. JCI Insight 2018;3(14):e120183. 

Use of the Intermountain Risk Score together with the CHA2DS2-VASc risk score among people with atrial fibrillation.

Graves KG, et al. Open Heart 2018;5:e000907.

Risk score for identifying heart failure patients at risk of returning for additional hospitalization within 30 days of a first hospitalization.

Primary care risk score for evaluating risk of chronic diseases among people with depression.

May HT, et al. Psychosomatics 2017;58:395-405.

Incident Heart Failure prediction using the Intermountain Major Adverse Cardiovascular Events (IMACE) Risk Scores

Horne BD, et al. Circulation 2016;134(suppl): (abstr)

All-cause mortality prediction for chronic kidney disease patients with classes IIIa, IIIb, IV, or V

Rassa AC, et al. Am J Nephrol 2016;42:443-450

Mental Health Integration: Predicts the new onset for any one of 10 chronic illnesses for patients with a mental health diagnosis

May HT et al. Circulation 2016; 134(suppl): (abstr)

Prediction of portal vein thrombosis from time patient is placed on wait list through liver transplant surgery.

Haseeb A, et al. Hepatology 2016;64(Suppl S1):126A

Expanded IMRS: Predicts all-cause mortality with the Expanded IMRS, using the comprehensive metabolic profile (instead of basic metabolic profile).

May HT, et al. Clin Chem Lab Med 2016;54:1619-1628.

Pilot study of clinical implementation of risk scores among hospitalized patients.

Evans RS, et al. J Am Med Inform Assoc 2016 Sep;23(5):872-8.

• All-cause mortality score
• Cardiovascular mortality score
• Combination of mortality, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization